Helios And Matheson Analytics Inc PE Ratio 2012-2018 | HMNY
Current and historical p/e ratio for Helios And Matheson Analytics Inc (HMNY) from 2012 to 2018. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Helios And Matheson Analytics Inc PE ratio as of June 10, 2026 is 0.00.
| Helios And Matheson Analytics Inc PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2026-06-09 | 0.00 | 0.00 | |
| 2018-09-30 | 0.02 | $-3,978.20 | 0.00 |
| 2018-06-30 | 77.50 | $-3,983.79 | 0.00 |
| 2018-03-31 | 707.50 | $-4,050.00 | 0.00 |
| 2017-12-31 | 1577.50 | $-4,365.00 | 0.00 |
| 2017-09-30 | 3172.50 | $-1,054.47 | 0.00 |
| 2017-06-30 | 607.50 | $-1,148.68 | 0.00 |
| 2017-03-31 | 707.50 | $-962.50 | 0.00 |
| 2016-12-31 | 825.00 | $-685.00 | 0.00 |
| 2016-09-30 | 2035.00 | $-125.00 | 0.00 |
| 2016-06-30 | 2287.50 | $-267.50 | 0.00 |
| 2016-03-31 | 300.00 | $-247.50 | 0.00 |
| 2015-12-31 | 347.50 | $-227.50 | 0.00 |
| 2015-09-30 | 520.03 | $-230.00 | 0.00 |
| 2015-06-30 | 607.50 | $10.00 | 60.75 |
| 2015-03-31 | 625.00 | $-5.00 | 0.00 |
| 2014-12-31 | 499.98 | $-20.00 | 0.00 |
| 2014-09-30 | 652.50 | $-15.00 | 0.00 |
| 2014-06-30 | 992.50 | 0 | 0.00 |
| 2014-03-31 | 1287.50 | $20.00 | 64.38 |
| 2013-12-31 | 1417.91 | $40.00 | 35.45 |
| 2013-09-30 | 1602.85 | $52.50 | 30.53 |
| 2013-06-30 | 1075.14 | $55.00 | 19.55 |
| 2013-03-31 | 838.42 | $52.50 | 15.97 |
| 2012-12-31 | 884.59 | $45.00 | 19.66 |
| 2012-09-30 | 550.70 | $52.50 | 10.49 |
| 2012-06-30 | 699.15 | $45.00 | 15.54 |
| 2012-03-31 | 914.64 | $37.50 | 24.39 |
| 2011-12-31 | 482.34 | $22.50 | 21.44 |
| 2011-09-30 | 280.14 | $-21.25 | 0.00 |
| 2011-06-30 | 766.19 | $-28.75 | 0.00 |
| 2011-03-31 | 528.55 | $-118.75 | 0.00 |
| 2010-12-31 | 395.13 | $-181.25 | 0.00 |
| 2010-09-30 | 448.94 | $-231.25 | 0.00 |
| 2010-06-30 | 508.80 | $-375.00 | 0.00 |
| 2010-03-31 | 735.66 | $-406.25 | 0.00 |
| 2009-12-31 | 425.00 | $-525.00 | 0.00 |
| 2009-09-30 | 251.41 | $-456.25 | 0.00 |
| 2009-06-30 | 263.38 | $-393.75 | 0.00 |
| 2009-03-31 | 359.15 | $-418.75 | 0.00 |
| 2008-12-31 | 269.36 | $-225.00 | 0.00 |
| 2008-09-30 | 1089.42 | $-281.25 | 0.00 |
| 2008-06-30 | 1185.20 | $-268.75 | 0.00 |
| 2008-03-31 | 1340.83 | $-275.00 | 0.00 |
| 2007-12-31 | 1137.31 | $-218.75 | 0.00 |
| 2007-09-30 | 2065.12 | $-87.50 | 0.00 |
| 2007-06-30 | 2945.03 | $-12.50 | 0.00 |
| 2007-03-31 | 2316.52 | $318.75 | 7.27 |
| 2006-12-31 | 1903.50 | $225.00 | 8.46 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical - Outpatient & Home Care | $0.000B | $0.000B |
| The A Consulting Team (TACT) is a consulting firm organized into three components: Application Development, Database Management, and Networking Systems/Communication. Backed up by this extensive technical organization, TACT's three departments, which consist of Consulting, Software and Technical Training, distribute state-of-the-art technical knowledge and capabilities to meet any business goal. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Fresenius SE (FSNUY) | Germany | $29.514B | 13.37 |
| Quest Diagnostics (DGX) | United States | $21.197B | 19.44 |
| Elanco Animal Health (ELAN) | United States | $11.500B | 24.35 |
| Encompass Health (EHC) | United States | $10.662B | 19.64 |
| DaVita (DVA) | United States | $10.023B | 13.82 |
| Chemed (CHE) | United States | $5.639B | 19.57 |
| Option Care Health (OPCH) | United States | $4.553B | 18.71 |
| RadNet (RDNT) | United States | $4.302B | 142.13 |
| LifeStance Health (LFST) | United States | $2.495B | 320.00 |
| Addus HomeCare (ADUS) | United States | $1.719B | 16.61 |
| Astrana Health (ASTH) | United States | $1.536B | 31.40 |
| Aveanna Healthcare Holdings (AVAH) | United States | $1.353B | 12.20 |
| U.S Physical Therapy (USPH) | United States | $1.157B | 29.19 |
| Pennant (PNTG) | United States | $1.072B | 31.31 |
| Daxor (DXR) | United States | $0.048B | 0.00 |
| MEDIROM Healthcare Technologies (MRM) | Japan | $0.032B | 0.00 |
| Psychemedics (PMD) | United States | $0.000B | 0.00 |